Ardelyx, Inc.

Biotechnology • Healthcare • Waltham, MA, United States • ARDX (NGM)

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

510 745 1700 400 Fifth Avenue, Waltham, MA 02451, United States

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Wall Street Analysts See a 92.12% Upside in Ardelyx (ARDX): Can the Stock Really Move This High? - Zacks Investment Research

Zacks Investment Research • Jan 6

Ardelyx stock jumps as Raymond James notes price hikes - Investing.com

Investing.com • Jan 2

Ardelyx Stock Gains Momentum After Positive Developments - StocksToTrade

StocksToTrade • Jan 4

Ardelyx (NASDAQ:ARDX) Shares Down 6.9% - Here's Why - MarketBeat

MarketBeat • Jan 5

Ardelyx Stock Rises Amid Market Developments - timothysykes.com

timothysykes.com • Jan 2

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has ARDELYX, INC. had layoffs?

No layoff events have been recorded for ARDELYX, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does ARDELYX, INC. have?

ARDELYX, INC. has approximately 395 employees.

What industry is ARDELYX, INC. in?

ARDELYX, INC. operates in the Biotechnology industry, within the Healthcare sector.

Is ARDELYX, INC. a publicly traded company?

Yes, ARDELYX, INC. is publicly traded under the ticker symbol ARDX on the NGM. The company has a market capitalization of approximately $1.39 billion.

Where is ARDELYX, INC. headquartered?

ARDELYX, INC. is headquartered in Waltham, MA, United States at 400 Fifth Avenue, Waltham, MA 02451, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.